Commonwealth Consolidated Regulations

THERAPEUTIC GOODS REGULATIONS 1990 - REG 35B

  (1)   The Minister may appoint, in writing, up to 20 persons to the committee in accordance with subregulations (1A) and (1B).

  (1A)   Subject to subregulation   (1B):

  (a)   to the extent reasonably practicable, membership of the committee is to represent the widest possible range of fields mentioned in subregulation   (2); and

  (b)   each member of the committee must have expertise in at least one of those fields.

  (1B)   One member of the committee may have expertise in consumer health issues.

  (2)   For the purposes of subregulation   (1A), the fields are as follows:

  (a)   general medical practice in Australia;

  (b)   specialist medical practice of a kind that is relevant to the committee's functions;

  (c)   epidemiology or biostatistics;

  (d)   clinical pharmacology or pharmacokinetics;

  (e)   paediatrics;

  (f)   gerontology;

  (g)   internal medicine, including the following:

  (i)   haematology;

  (ii)   oncology;

  (iii)   infectious diseases;

  (iv)   cardiology;

  (v)   gastroenterology or hepatology;

  (vi)   renal disease;

  (vii)   endocrinology;

  (viii)   neurology;

  (ix)   immunology;

  (x)   rheumatology;

  (xi)   respiratory disease;

  (h)   intensive care;

  (i)   anaesthetics;

  (j)   psychiatry;

  (k)   toxicology;

  (l)   pharmaceutical chemistry;

  (m)   microbiology;

  (n)   community or clinical pharmacy;

  (o)   manufacture of medicines;

  (p)   dermatology;

  (q)   obstetrics or gynaecology;

  (r)   ophthalmology;

  (s)   radiology;

  (t)   medical genetics;

  (u)   developmental or reproductive toxicology;

  (v)   medicines in pregnancy;

  (w)   medical ethics.